ALZECURE PHARMA (Germany) Market Value
| AC6 Stock | EUR 0.30 0.02 7.14% |
| Symbol | ALZECURE |
ALZECURE PHARMA 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ALZECURE PHARMA's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ALZECURE PHARMA.
| 04/23/2025 |
| 07/22/2025 |
If you would invest 0.00 in ALZECURE PHARMA on April 23, 2025 and sell it all today you would earn a total of 0.00 from holding ALZECURE PHARMA AB or generate 0.0% return on investment in ALZECURE PHARMA over 90 days. ALZECURE PHARMA is related to or competes with Zoetis, Shionogi, Ipsen SA, and Dr Reddys. AlzeCure Pharma AB , a pharmaceutical company, develops drug therapies for the treatment of Alzheimers and Parkinsons di... More
ALZECURE PHARMA Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ALZECURE PHARMA's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ALZECURE PHARMA AB upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 16.18 | |||
| Information Ratio | 0.1217 | |||
| Maximum Drawdown | 67.04 | |||
| Value At Risk | (23.33) | |||
| Potential Upside | 31.82 |
ALZECURE PHARMA Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ALZECURE PHARMA's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ALZECURE PHARMA's standard deviation. In reality, there are many statistical measures that can use ALZECURE PHARMA historical prices to predict the future ALZECURE PHARMA's volatility.| Risk Adjusted Performance | 0.1318 | |||
| Jensen Alpha | 2.05 | |||
| Total Risk Alpha | (0.23) | |||
| Sortino Ratio | 0.1144 | |||
| Treynor Ratio | (4.38) |
ALZECURE PHARMA AB Backtested Returns
ALZECURE PHARMA is out of control given 3 months investment horizon. ALZECURE PHARMA AB secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13 % return per unit of volatility over the last 3 months. We were able to interpolate twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.99% are justified by taking the suggested risk. Use ALZECURE PHARMA mean deviation of 11.16, and Risk Adjusted Performance of 0.1318 to evaluate company specific risk that cannot be diversified away. ALZECURE PHARMA holds a performance score of 10 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -0.45, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning ALZECURE PHARMA are expected to decrease at a much lower rate. During the bear market, ALZECURE PHARMA is likely to outperform the market. Use ALZECURE PHARMA treynor ratio, value at risk, downside variance, as well as the relationship between the maximum drawdown and potential upside , to analyze future returns on ALZECURE PHARMA.
Auto-correlation | -0.05 |
Very weak reverse predictability
ALZECURE PHARMA AB has very weak reverse predictability. Overlapping area represents the amount of predictability between ALZECURE PHARMA time series from 23rd of April 2025 to 7th of June 2025 and 7th of June 2025 to 22nd of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ALZECURE PHARMA AB price movement. The serial correlation of -0.05 indicates that only as little as 5.0% of current ALZECURE PHARMA price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.05 | |
| Spearman Rank Test | 0.11 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
ALZECURE PHARMA AB lagged returns against current returns
Autocorrelation, which is ALZECURE PHARMA stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ALZECURE PHARMA's stock expected returns. We can calculate the autocorrelation of ALZECURE PHARMA returns to help us make a trade decision. For example, suppose you find that ALZECURE PHARMA has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
ALZECURE PHARMA regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ALZECURE PHARMA stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ALZECURE PHARMA stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ALZECURE PHARMA stock over time.
Current vs Lagged Prices |
| Timeline |
ALZECURE PHARMA Lagged Returns
When evaluating ALZECURE PHARMA's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ALZECURE PHARMA stock have on its future price. ALZECURE PHARMA autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ALZECURE PHARMA autocorrelation shows the relationship between ALZECURE PHARMA stock current value and its past values and can show if there is a momentum factor associated with investing in ALZECURE PHARMA AB.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in ALZECURE Stock
ALZECURE PHARMA financial ratios help investors to determine whether ALZECURE Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ALZECURE with respect to the benefits of owning ALZECURE PHARMA security.